학술논문
18239 Secukinumab treatment results in sustained improvement in absolute PASI and drug survival: 24-month follow-up from the British Association of Dermatologists Biologics and Immunomodulators Register
Document Type
Abstract
Author
Source
In Journal of the American Academy of Dermatology December 2020 83(6) Supplement:AB94-AB94
Subject
Language
ISSN
0190-9622